Skip to main content
. 2013 Nov 14;134(6):1495–1503. doi: 10.1002/ijc.28454

Figure 2.

Figure 2

In the absence of XPF, oxaliplatin treatment causes persistence of double-strand breaks in mammalian cells. (a) CHO cells (10,000) were treated with 10 µM oxaliplatin (OX) for 2 hr in a 96-well plate and fixed in 4% paraformaldehyde at various time points, blocked with 0.1% Triton X-100 and 1% bovine serum albumin (BSA) in PBS before being stained for γH2AX (b) and 53BP1 (c) foci (1:2000 for γH2AX and 1:1000 for 53BP1 in 1% BSA) overnight. A 1:500 dilution of Alexa fluor 488-labeled secondary antibody was diluted in 1% BSA in PBS and incubated for 1 hr at room temperature, and then cells were stained with a 1:2000 dilution of 1 mg/ml DAPI (Sigma Aldrich) for 10 min at RT before being analyzed on IN Cell Analyser 1000 (GE Life Sciences), counting cells with more than 8 foci per nucleus. Data (b,c) are plotted versus time for WT DMSO (Inline graphic), WT 10 µM oxaliplatin (Inline graphic), XPF DMSO (Inline graphic) and XPF 10 µM oxaliplatin (Inline graphic). (n = 3, error bars = standard deviation).